Genito-Urinary Drugs
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Gastrointestinal Drugs Market Research Report 2024
1 Gastrointestinal Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Gastrointestinal Drugs Segment by Type
1.2.1 Global Gastrointestinal Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Gastrointestinal Drugs Segment by Application
1.3.1 Global Gastrointestinal Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Global Gastrointestinal Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal Drugs Revenue 2017-2028
1.4.2 Global Gastrointestinal Drugs Sales 2017-2028
1.4.3 Gastrointestinal Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Gastrointestinal Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Gastrointestinal Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Gastrointestinal Drugs Manufacturing Sites, Area Served, Product Type
2.5 Gastrointestinal Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gastrointestinal Drugs Players Market Share by Revenue
2.5.3 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastrointestinal Drugs Retrospective Market Scenario by Region
3.1 Global Gastrointestinal Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Gastrointestinal Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Gastrointestinal Drugs Market Facts & Figures by Country
3.3.1 North America Gastrointestinal Drugs Sales by Country
3.3.2 North America Gastrointestinal Drugs Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Gastrointestinal Drugs Market Facts & Figures by Country
3.4.1 Europe Gastrointestinal Drugs Sales by Country
3.4.2 Europe Gastrointestinal Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Gastrointestinal Drugs Sales by Region
3.5.2 Asia Pacific Gastrointestinal Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Gastrointestinal Drugs Market Facts & Figures by Country
3.6.1 Latin America Gastrointestinal Drugs Sales by Country
3.6.2 Latin America Gastrointestinal Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Gastrointestinal Drugs Sales by Country
3.7.2 Middle East and Africa Gastrointestinal Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gastrointestinal Drugs Historic Market Analysis by Type
4.1 Global Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
4.2 Global Gastrointestinal Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Gastrointestinal Drugs Price by Type (2017-2022)
5 Global Gastrointestinal Drugs Historic Market Analysis by Application
5.1 Global Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
5.2 Global Gastrointestinal Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Gastrointestinal Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AstraZeneca Gastrointestinal Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Sanofi Gastrointestinal Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bayer Gastrointestinal Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Gastrointestinal Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 GlaxoSmithKline Gastrointestinal Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Teva Gastrointestinal Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Zeria (Tillotts)
6.6.1 Zeria (Tillotts) Corporation Information
6.6.2 Zeria (Tillotts) Description and Business Overview
6.6.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Zeria (Tillotts) Gastrointestinal Drugs Product Portfolio
6.7.5 Zeria (Tillotts) Recent Developments/Updates
6.8 Perrigo
6.8.1 Perrigo Corporation Information
6.8.2 Perrigo Description and Business Overview
6.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Perrigo Gastrointestinal Drugs Product Portfolio
6.8.5 Perrigo Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Purdue Pharma
6.10.1 Purdue Pharma Corporation Information
6.10.2 Purdue Pharma Description and Business Overview
6.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Purdue Pharma Gastrointestinal Drugs Product Portfolio
6.10.5 Purdue Pharma Recent Developments/Updates
6.11 C.B. Fleet
6.11.1 C.B. Fleet Corporation Information
6.11.2 C.B. Fleet Gastrointestinal Drugs Description and Business Overview
6.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 C.B. Fleet Gastrointestinal Drugs Product Portfolio
6.11.5 C.B. Fleet Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Gastrointestinal Drugs Description and Business Overview
6.12.3 Abbott Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Abbott Gastrointestinal Drugs Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Jiangzhong
6.13.1 Jiangzhong Corporation Information
6.13.2 Jiangzhong Gastrointestinal Drugs Description and Business Overview
6.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Jiangzhong Gastrointestinal Drugs Product Portfolio
6.13.5 Jiangzhong Recent Developments/Updates
6.14 Xian-Janssen
6.14.1 Xian-Janssen Corporation Information
6.14.2 Xian-Janssen Gastrointestinal Drugs Description and Business Overview
6.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Xian-Janssen Gastrointestinal Drugs Product Portfolio
6.14.5 Xian-Janssen Recent Developments/Updates
7 Gastrointestinal Drugs Manufacturing Cost Analysis
7.1 Gastrointestinal Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gastrointestinal Drugs
7.4 Gastrointestinal Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gastrointestinal Drugs Distributors List
8.3 Gastrointestinal Drugs Customers
9 Gastrointestinal Drugs Market Dynamics
9.1 Gastrointestinal Drugs Industry Trends
9.2 Gastrointestinal Drugs Market Drivers
9.3 Gastrointestinal Drugs Market Challenges
9.4 Gastrointestinal Drugs Market Restraints
10 Global Market Forecast
10.1 Gastrointestinal Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gastrointestinal Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Gastrointestinal Drugs by Type (2023-2028)
10.2 Gastrointestinal Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gastrointestinal Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Gastrointestinal Drugs by Application (2023-2028)
10.3 Gastrointestinal Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gastrointestinal Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Gastrointestinal Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Gastrointestinal Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Gastrointestinal Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Gastrointestinal Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Gastrointestinal Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Gastrointestinal Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Gastrointestinal Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Gastrointestinal Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Gastrointestinal Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Gastrointestinal Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Gastrointestinal Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Gastrointestinal Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Gastrointestinal Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Gastrointestinal Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Gastrointestinal Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Gastrointestinal Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Gastrointestinal Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Gastrointestinal Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Gastrointestinal Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Gastrointestinal Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Gastrointestinal Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Gastrointestinal Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Gastrointestinal Drugs Revenue Share by Type (2017-2022)
Table 43. Global Gastrointestinal Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Gastrointestinal Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Gastrointestinal Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Gastrointestinal Drugs Revenue Share by Application (2017-2022)
Table 48. Global Gastrointestinal Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. AstraZeneca Corporation Information
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. AstraZeneca Gastrointestinal Drugs Product
Table 53. AstraZeneca Recent Developments/Updates
Table 54. Sanofi Corporation Information
Table 55. Sanofi Description and Business Overview
Table 56. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Sanofi Gastrointestinal Drugs Product
Table 58. Sanofi Recent Developments/Updates
Table 59. Bayer Corporation Information
Table 60. Bayer Description and Business Overview
Table 61. Bayer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Bayer Gastrointestinal Drugs Product
Table 63. Bayer Recent Developments/Updates
Table 64. Pfizer Corporation Information
Table 65. Pfizer Description and Business Overview
Table 66. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Pfizer Gastrointestinal Drugs Product
Table 68. Pfizer Recent Developments/Updates
Table 69. GlaxoSmithKline Corporation Information
Table 70. GlaxoSmithKline Description and Business Overview
Table 71. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. GlaxoSmithKline Gastrointestinal Drugs Product
Table 73. GlaxoSmithKline Recent Developments/Updates
Table 74. Teva Corporation Information
Table 75. Teva Description and Business Overview
Table 76. Teva Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Teva Gastrointestinal Drugs Product
Table 78. Teva Recent Developments/Updates
Table 79. Zeria (Tillotts) Corporation Information
Table 80. Zeria (Tillotts) Description and Business Overview
Table 81. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Zeria (Tillotts) Gastrointestinal Drugs Product
Table 83. Zeria (Tillotts) Recent Developments/Updates
Table 84. Perrigo Corporation Information
Table 85. Perrigo Description and Business Overview
Table 86. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Perrigo Gastrointestinal Drugs Product
Table 88. Perrigo Recent Developments/Updates
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Business Overview
Table 91. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Boehringer Ingelheim Gastrointestinal Drugs Product
Table 93. Boehringer Ingelheim Recent Developments/Updates
Table 94. Purdue Pharma Corporation Information
Table 95. Purdue Pharma Description and Business Overview
Table 96. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Purdue Pharma Gastrointestinal Drugs Product
Table 98. Purdue Pharma Recent Developments/Updates
Table 99. C.B. Fleet Corporation Information
Table 100. C.B. Fleet Description and Business Overview
Table 101. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. C.B. Fleet Gastrointestinal Drugs Product
Table 103. C.B. Fleet Recent Developments/Updates
Table 104. Abbott Corporation Information
Table 105. Abbott Description and Business Overview
Table 106. Abbott Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Abbott Gastrointestinal Drugs Product
Table 108. Abbott Recent Developments/Updates
Table 109. Jiangzhong Corporation Information
Table 110. Jiangzhong Description and Business Overview
Table 111. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Jiangzhong Gastrointestinal Drugs Product
Table 113. Jiangzhong Recent Developments/Updates
Table 114. Xian-Janssen Corporation Information
Table 115. Xian-Janssen Description and Business Overview
Table 116. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Xian-Janssen Gastrointestinal Drugs Product
Table 118. Xian-Janssen Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Gastrointestinal Drugs Distributors List
Table 122. Gastrointestinal Drugs Customers List
Table 123. Gastrointestinal Drugs Market Trends
Table 124. Gastrointestinal Drugs Market Drivers
Table 125. Gastrointestinal Drugs Market Challenges
Table 126. Gastrointestinal Drugs Market Restraints
Table 127. Global Gastrointestinal Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 128. Global Gastrointestinal Drugs Sales Market Share Forecast by Type (2023-2028)
Table 129. Global Gastrointestinal Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 130. Global Gastrointestinal Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 131. Global Gastrointestinal Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 132. Global Gastrointestinal Drugs Sales Market Share Forecast by Application (2023-2028)
Table 133. Global Gastrointestinal Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 134. Global Gastrointestinal Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 135. Global Gastrointestinal Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 136. Global Gastrointestinal Drugs Sales Market Share Forecast by Region (2023-2028)
Table 137. Global Gastrointestinal Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 138. Global Gastrointestinal Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gastrointestinal Drugs
Figure 2. Global Gastrointestinal Drugs Market Share by Type in 2021 & 2028
Figure 3. Prescription Gastrointestinal Drug Product Picture
Figure 4. OTC Gastrointestinal Drug Product Picture
Figure 5. Global Gastrointestinal Drugs Market Share by Application in 2021 & 2028
Figure 6. Chronic Gastritis
Figure 7. Functional Dyspepsia
Figure 8. Peptic Ulcer
Figure 9. Acute Gastroenteritis
Figure 10. Other
Figure 11. Global Gastrointestinal Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Gastrointestinal Drugs Market Size (2017-2028) & (US$ Million)
Figure 13. Global Gastrointestinal Drugs Sales (2017-2028) & (K Units)
Figure 14. Gastrointestinal Drugs Sales Share by Manufacturers in 2021
Figure 15. Global Gastrointestinal Drugs Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Gastrointestinal Drugs Players: Market Share by Revenue in 2021
Figure 17. Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Gastrointestinal Drugs Sales Market Share by Region (2017-2022)
Figure 19. Global Gastrointestinal Drugs Sales Market Share by Region in 2021
Figure 20. Global Gastrointestinal Drugs Revenue Market Share by Region (2017-2022)
Figure 21. Global Gastrointestinal Drugs Revenue Market Share by Region in 2021
Figure 22. the United States Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. UK Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Gastrointestinal Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Gastrointestinal Drugs by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Gastrointestinal Drugs
Figure 46. Manufacturing Process Analysis of Gastrointestinal Drugs
Figure 47. Gastrointestinal Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca Sanofi Bayer Pfizer GlaxoSmithKline Teva Zeria (Tillotts) Perrigo Boehringer Ingelheim Purdue Pharma C.B. Fleet Abbott Jiangzhong Xian-Janssen